Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 7, 2022Gut MicrobesOpen Access

Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYongkang LaiSecond Military Medical UniversityWWWei WeiLiaoning University of Traditional Chinese MedicineYDYiqi DuSecond Military Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lai et al. (2022) studied this question.

synapsesocial.com/papers/6a01d27d897643a80dcb0fe0https://doi.org/10.1080/19490976.2022.2120747
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Helicobacter pylori Virulence Factors—Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment2020 · 369 citations
  2. 2Lower impact of vonoprazan–amoxicillin dual therapy on gut microbiota for<i>Helicobacter pylori</i>eradication2021 · 48 citations
  3. 3<i>Helicobacter pylori</i>eradication therapy to prevent gastric cancer: systematic review and meta-analysis2020 · 465 citations
  4. 4Kyoto global consensus report on<i>Helicobacter pylori</i>gastritis2015 · 1,822 citations